Dudediligence.

Tyra Biosciences, Inc

TYRANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$33.1M

15 notices · 1,236,717 sh

Oct 2025 to Oct 2026

Reported ·

$10.6M

14 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

13 of 14 reported sales carry the 10b5-1 box. Together they are 0.93% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-26: NEXTECH VI ONCOLOGY SCSP, Form 1442026-06-01: NEXTECH VI ONCOLOGY SCSP, Form 1442026-05-12: Daniel Bensen, Form 1442026-04-13: Daniel Bensen, Form 1442026-03-26: GILLA KAPLAN, Form 1442026-03-25: GILLA KAPLAN, Form 1442026-03-12: Daniel Bensen, Form 1442026-02-12: Daniel Bensen, Form 1442026-01-12: Daniel Bensen, Form 1442025-12-12: Daniel Bensen, Form 1442025-11-21: Alta Partners NextGen Fund II, L.P., Form 1442025-11-18: Daniel Bensen, Form 1442025-11-17: Daniel Bensen, Form 1442025-11-14: Daniel Bensen, Form 1442025-11-13: Daniel Bensen, Form 1442025-11-13: Bensen Daniel, sold2025-11-18: Bensen Daniel, sold2025-11-21: MORE ROBERT J, sold2025-12-12: Bensen Daniel, sold2025-12-19: MORE ROBERT J, sold2026-01-12: Bensen Daniel, sold2026-02-12: Bensen Daniel, sold2026-03-25: KAPLAN GILLA, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-06-26NEXTECH VI ONCOLOGY SCSP, Shareholder$9,541,246
308,379 shplan 2026-03-02Form 4s on file end Jun 23144 ↗
2026-06-01NEXTECH VI ONCOLOGY SCSP, Shareholder$10.0M
300,000 shplan 2026-03-02Form 4s on file end Jun 23144 ↗
2026-05-12Daniel Bensen, Chief Discovery Officer$274,000
8,000 shplan 2024-11-05Form 4s on file end Jun 23144 ↗
2026-04-13Daniel Bensen, Chief Discovery Officer$285,000
8,000 shplan 2024-11-05Form 4s on file end Jun 23144 ↗
2026-03-26GILLA KAPLAN, Director$2,007,153
53,172 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-25GILLA KAPLAN, Director$528,506
14,295 shno plan date144 ↗
Form 4, 2026-03-27: sold 14,295 at $36.97 Form 4 ↗
2026-03-12Daniel Bensen, Chief Discovery Officer$283,000
8,000 shplan 2024-11-05no Form 4 on file144 ↗
2026-02-12Daniel Bensen, Chief Discovery Officer$262,000
8,000 shplan 2024-11-05144 ↗
Form 4, 2026-02-13: sold 8,000 at $32.87 Form 4 ↗
2026-01-12Daniel Bensen, Chief Discovery Officer$232,000
8,000 shplan 2024-11-05144 ↗
Form 4, 2026-01-20: sold 8,000 at $28.52 Form 4 ↗
2025-12-12Daniel Bensen, Chief Discovery Officer$180,000
8,000 sh10b5-1 plan144 ↗
Form 4, 2025-12-16: sold 8,000 at $22.64 Form 4 ↗
2025-11-21Alta Partners NextGen Fund II, L.P., Affiliate$5,394,291
256,871 shplan 2025-06-26no Form 4 on file144 ↗
2025-11-18Daniel Bensen, Chief Discovery Officer$2,000,000
124,589 shplan 2024-11-05144 ↗
Form 4, 2025-11-19: sold 125,589 at $16.17 Form 4 ↗
2025-11-17Daniel Bensen, Chief Discovery Officer$320,000
20,072 shno plan dateno Form 4 on file144 ↗
2025-11-14Daniel Bensen, Chief Discovery Officer$1,380,000
86,339 shplan 2024-11-04no Form 4 on file144 ↗
2025-11-13Daniel Bensen, Chief Discovery Officer$400,000
25,000 shplan 2024-11-04144 ↗
Form 4, 2025-11-17: sold 131,411 at $16.04 Form 4 ↗